In our study, in 6 patients clinically diagnosed with IPAH, homozygous or compound heterozygous EIF2AK4 mutations were detected; thus, their diagnosis should be corrected to PVOD. This evidence concerns the gene EIF2AK4 and pulmonary venoocclusive disease.